KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Recursion Pharmaceuticals (RXRX) Intangibles: 2020-2025

Historic Intangibles for Recursion Pharmaceuticals (RXRX) over the last 4 years, with Sep 2025 value amounting to $322.3 million.

  • Recursion Pharmaceuticals' Intangibles rose 845.48% to $322.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $322.3 million, marking a year-over-year increase of 845.48%. This contributed to the annual value of $335.9 million for FY2024, which is 821.59% up from last year.
  • Recursion Pharmaceuticals' Intangibles amounted to $322.3 million in Q3 2025, which was down 5.56% from $341.3 million recorded in Q2 2025.
  • Over the past 5 years, Recursion Pharmaceuticals' Intangibles peaked at $341.3 million during Q2 2025, and registered a low of $1.2 million during Q2 2022.
  • For the 3-year period, Recursion Pharmaceuticals' Intangibles averaged around $141.9 million, with its median value being $39.5 million (2023).
  • Its Intangibles has fluctuated over the past 5 years, first declined by 18.00% in 2021, then skyrocketed by 3,367.72% in 2023.
  • Recursion Pharmaceuticals' Intangibles (Quarterly) stood at $1.4 million in 2021, then declined by 5.70% to $1.3 million in 2022, then surged by 2,690.43% to $36.4 million in 2023, then soared by 821.59% to $335.9 million in 2024, then soared by 845.48% to $322.3 million in 2025.
  • Its Intangibles was $322.3 million in Q3 2025, compared to $341.3 million in Q2 2025 and $335.8 million in Q1 2025.